In the December 2011 issue, the article entitled 'Class of once-weekly diabetes drugs poised for approval' (Nat. Med. 17, 1528, 2011) incorrectly stated that the pharmaceutical company Eli Lilly is based in New York, when in fact its headquarters are in Indiana. The error has been corrected in the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nm1211-1528b
Rights and permissions
About this article
Cite this article
Correction. Nat Med 18, 337 (2012). https://doi.org/10.1038/nm0312-337
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0312-337
